According to new study published in Circulation: Cardiovascular Imaging, psoriasis in patients treated with biologic remedy had a noteworthy decrease in high-risk plaque in heart arteries over 1 year.

Chronic inflammation in individuals with psoriasis is linked with a complex risk of developing coronary artery disease. Biologic therapy medications are proteins that are given by injection or infusion and overwhelm the inflammation process by delaying the action of cytokines, which are proteins that encourage systemic inflammation.

The outcome of the study must be interpreted with caution because it was limited by a small follow-up period and a moderately small number of patients, according to the authors. Future studies should involve greater, randomized controlled studies to better understand how changes in coronary plaque may lead to a reduction in heart attacks and strokes in people with psoriasis.